VivoSim Labs, Inc. Earnings Per Share (Basic)
VivoSim Labs, Inc. (VIVS) reported Earnings Per Share (Basic) of -$0.25 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- VivoSim Labs, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.25.
- VivoSim Labs, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$2.19, a 151.89% decline year-over-year.
- VivoSim Labs, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$1.03.
- VivoSim Labs, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.98.
- VivoSim Labs, Inc. earnings per share, basic for fiscal 2026 was -$5.35.
- VivoSim Labs, Inc. earnings per share, basic for fiscal 2025 was -$1.70.
- VivoSim Labs, Inc. earnings per share, basic for fiscal 2024 was -$19.25.
- VivoSim Labs, Inc. earnings per share, basic for fiscal 2023 was -$1.98.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.25 10-Q · filed 2026-08-12 | -$1.80 derived: net income ÷ weighted average shares · filed 2026-08-21 | -$2.80 derived: net income ÷ weighted average shares · filed 2026-08-21 | -$3.77 derived: net income ÷ weighted average shares · filed 2026-08-21 | ||||
| 2026-03-31 | -$2.19 derived: net income ÷ weighted average shares · filed 2026-08-21 | -$3.22 derived: net income ÷ weighted average shares · filed 2026-08-21 | -$4.20 derived: net income ÷ weighted average shares · filed 2026-08-21 | -$5.35 10-K · filed 2026-07-14 | ||||
| 2025-12-31 | -$1.03 10-Q · filed 2026-02-11 | -$2.01 derived: net income ÷ weighted average shares · filed 2026-02-11 | -$3.14 10-Q · filed 2026-02-11 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-08-21 | ||||
| 2025-09-30 | -$0.98 10-Q · filed 2025-11-06 | -$2.11 10-Q · filed 2025-11-06 | $0.65 derived: net income ÷ weighted average shares · filed 2026-08-21 | -$0.96 derived: net income ÷ weighted average shares · filed 2026-08-21 | ||||
| 2025-06-30 | -$1.14 10-Q · filed 2026-08-12 | $1.94 derived: net income ÷ weighted average shares · filed 2026-08-21 | $0.30 derived: net income ÷ weighted average shares · filed 2026-08-21 | -$1.11 derived: net income ÷ weighted average shares · filed 2026-08-21 | ||||
| 2025-03-31 | $4.21 derived: net income ÷ weighted average shares · filed 2026-08-21 | $2.18 derived: net income ÷ weighted average shares · filed 2026-08-21 | $0.55 derived: net income ÷ weighted average shares · filed 2026-08-21 | -$1.70 10-K · filed 2026-07-14 | ||||
| 2024-12-31 | -$2.28 10-Q · filed 2026-02-11 | -$0.19 10-Q · filed 2025-02-19 | -$3.99 derived: net income ÷ weighted average shares · filed 2026-02-11 | -$6.60 10-Q · filed 2026-02-11 | -$0.55 10-Q · filed 2025-02-19 | $2.57 derived: net income ÷ weighted average shares · filed 2026-08-21 | ||
| 2024-09-30 | -$1.68 10-Q · filed 2025-11-06 | -$0.14 10-Q · filed 2024-11-08 | -$4.32 10-Q · filed 2025-11-06 | -$0.36 10-Q · filed 2024-11-08 | $1.29 derived: net income ÷ weighted average shares · filed 2026-08-21 | $4.30 derived: net income ÷ weighted average shares · filed 2026-08-21 | ||
| 2024-06-30 | -$2.74 10-Q · filed 2025-08-12 | -$0.23 10-Q · filed 2024-08-05 | $0.57 derived: net income ÷ weighted average shares · filed 2026-08-21 | $2.28 derived: net income ÷ weighted average shares · filed 2026-08-21 | $12.58 derived: net income ÷ weighted average shares · filed 2026-08-21 | |||
| 2024-03-31 | $0.13 derived: net income ÷ weighted average shares · filed 2026-08-21 | $0.92 derived: net income ÷ weighted average shares · filed 2026-08-21 | $5.63 derived: net income ÷ weighted average shares · filed 2026-08-21 | -$19.25 10-K · filed 2025-06-05 | -$1.60 10-K · filed 2024-05-31 | |||
| 2023-12-31 | -$0.40 10-Q · filed 2025-02-19 | -$0.85 derived: net income ÷ weighted average shares · filed 2025-02-19 | -$1.31 10-Q · filed 2025-02-19 | -$2.16 derived: net income ÷ weighted average shares · filed 2025-02-19 | ||||
| 2023-09-30 | -$0.46 10-Q · filed 2024-11-08 | -$0.92 10-Q · filed 2024-11-08 | -$1.78 derived: net income ÷ weighted average shares · filed 2024-11-08 | -$2.15 derived: net income ÷ weighted average shares · filed 2024-11-08 | ||||
| 2023-06-30 | -$0.46 10-Q · filed 2024-08-05 | -$1.32 derived: net income ÷ weighted average shares · filed 2024-08-05 | -$1.69 derived: net income ÷ weighted average shares · filed 2024-08-05 | -$2.07 derived: net income ÷ weighted average shares · filed 2024-08-05 | ||||
| 2023-03-31 | -$0.86 derived: net income ÷ weighted average shares · filed 2024-05-31 | -$1.23 derived: net income ÷ weighted average shares · filed 2024-05-31 | -$1.61 derived: net income ÷ weighted average shares · filed 2024-05-31 | -$1.98 10-K · filed 2024-05-31 | ||||
| 2022-12-31 | -$0.37 10-Q · filed 2024-02-08 | -$0.76 derived: net income ÷ weighted average shares · filed 2024-02-08 | -$1.13 10-Q · filed 2024-02-08 | -$1.34 derived: net income ÷ weighted average shares · filed 2024-02-08 | ||||
| 2022-09-30 | -$0.38 10-Q · filed 2023-11-09 | -$0.75 10-Q · filed 2023-11-09 | -$0.97 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.37 derived: net income ÷ weighted average shares · filed 2023-11-09 | ||||
| 2022-06-30 | -$0.37 10-Q · filed 2023-08-10 | -$0.59 derived: net income ÷ weighted average shares · filed 2023-08-10 | -$0.99 derived: net income ÷ weighted average shares · filed 2023-08-10 | -$1.39 derived: net income ÷ weighted average shares · filed 2023-08-10 | ||||
| 2022-03-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2023-07-14 | -$0.62 derived: net income ÷ weighted average shares · filed 2023-07-14 | -$1.02 derived: net income ÷ weighted average shares · filed 2023-07-14 | -$1.32 10-K · filed 2023-07-14 | ||||
| 2021-12-31 | -$0.40 10-Q · filed 2023-02-09 | -$0.80 derived: net income ÷ weighted average shares · filed 2023-02-09 | -$1.10 10-Q · filed 2023-02-09 | |||||
| 2021-09-30 | -$0.40 10-Q · filed 2022-11-10 | -$0.69 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | -$0.29 10-Q · filed 2022-08-11 | |||||||
| 2013-09-30 | -$0.14 10-Q · filed 2013-11-08 | -$0.21 10-Q · filed 2013-11-08 | ||||||
| 2012-09-30 | $0.87 10-Q · filed 2013-11-08 | $0.07 10-Q · filed 2013-11-08 | -$0.86 10-Q · filed 2012-11-14 | |||||
| 2011-09-30 | -$0.07 10-Q · filed 2012-11-14 | -$0.16 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |